|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 11612 |
FusionGeneSummary for ENO1_COL4A2 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: ENO1_COL4A2 | Fusion gene ID: 11612 | Hgene | Tgene | Gene symbol | ENO1 | COL4A2 | Gene ID | 2023 | 1284 |
| Gene name | enolase 1 | collagen type IV alpha 2 chain | |
| Synonyms | ENO1L1|HEL-S-17|MPB1|NNE|PPH | ICH|POREN2 | |
| Cytomap | 1p36.23 | 13q34 | |
| Type of gene | protein-coding | protein-coding | |
| Description | alpha-enolasec-myc promoter-binding protein-12-phospho-D-glycerate hydro-lyaseMYC promoter-binding protein 1alpha enolase like 1enolase 1, (alpha)enolase-alphaepididymis secretory protein Li 17non-neural enolasephosphopyruvate hydrataseplasminog | collagen alpha-2(IV) chaincanstatin | |
| Modification date | 20180523 | 20180523 | |
| UniProtAcc | P06733 | P08572 | |
| Ensembl transtripts involved in fusion gene | ENST00000234590, | ENST00000360467, ENST00000462309, | |
| Fusion gene scores | * DoF score | 14 X 15 X 7=1470 | 6 X 6 X 3=108 |
| # samples | 21 | 5 | |
| ** MAII score | log2(21/1470*10)=-2.8073549220576 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/108*10)=-1.11103131238874 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: ENO1 [Title/Abstract] AND COL4A2 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | ENO1 | GO:0000122 | negative regulation of transcription by RNA polymerase II | 2005901 |
| Hgene | ENO1 | GO:0030308 | negative regulation of cell growth | 10082554 |
| Hgene | ENO1 | GO:0045892 | negative regulation of transcription, DNA-templated | 10082554 |
| Hgene | ENO1 | GO:1903298 | negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway | 15459207 |
| Hgene | ENO1 | GO:2001171 | positive regulation of ATP biosynthetic process | 15459207 |
| Tgene | COL4A2 | GO:0016525 | negative regulation of angiogenesis | 10625665 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | AW362574 | ENO1 | chr1 | 8926485 | + | COL4A2 | chr13 | 111125307 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3CDS | ENST00000234590 | ENST00000360467 | ENO1 | chr1 | 8926485 | + | COL4A2 | chr13 | 111125307 | - |
| intron-intron | ENST00000234590 | ENST00000462309 | ENO1 | chr1 | 8926485 | + | COL4A2 | chr13 | 111125307 | - |
Top |
FusionProtFeatures for ENO1_COL4A2 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| ENO1 | COL4A2 |
| Type IV collagen is the major structural component ofglomerular basement membranes (GBM), forming a 'chicken-wire'meshwork together with laminins, proteoglycans andentactin/nidogen. Canstatin, a cleavage product corresponding to thecollagen alpha 2(IV) NC1 domain, possesses both anti-angiogenicand anti-tumor cell activity. It inhibits proliferation andmigration of endothelial cells, reduces mitochondrial membranepotential, and induces apoptosis. Specifically induces Fas-dependent apoptosis and activates procaspase-8 and -9 activity.Ligand for alphavbeta3 and alphavbeta5 integrins. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for ENO1_COL4A2 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for ENO1_COL4A2 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for ENO1_COL4A2 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Hgene | ENO1 | P06733 | DB01593 | Zinc | Alpha-enolase | small molecule | approved|investigational |
| Hgene | ENO1 | P06733 | DB11638 | Artenimol | Alpha-enolase | small molecule | approved|investigational |
Top |
RelatedDiseases for ENO1_COL4A2 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | ENO1 | C0001418 | Adenocarcinoma | 1 | CTD_human |
| Hgene | ENO1 | C0002395 | Alzheimer's Disease | 1 | CTD_human |
| Hgene | ENO1 | C0003873 | Rheumatoid Arthritis | 1 | CTD_human |
| Hgene | ENO1 | C0007131 | Non-Small Cell Lung Carcinoma | 1 | CTD_human |
| Hgene | ENO1 | C0007137 | Squamous cell carcinoma | 1 | CTD_human |
| Hgene | ENO1 | C0014859 | Esophageal Neoplasms | 1 | CTD_human |
| Hgene | ENO1 | C0021364 | Male infertility | 1 | CTD_human |
| Hgene | ENO1 | C0024667 | Animal Mammary Neoplasms | 1 | CTD_human |
| Hgene | ENO1 | C0024668 | Mammary Neoplasms, Experimental | 1 | CTD_human |
| Hgene | ENO1 | C0026640 | Mouth Neoplasms | 1 | CTD_human |
| Hgene | ENO1 | C0027626 | Neoplasm Invasiveness | 1 | CTD_human |
| Hgene | ENO1 | C0029408 | Degenerative polyarthritis | 1 | CTD_human |
| Hgene | ENO1 | C0029456 | Osteoporosis | 1 | CTD_human |
| Hgene | ENO1 | C0036341 | Schizophrenia | 1 | PSYGENET |
| Hgene | ENO1 | C0038356 | Stomach Neoplasms | 1 | CTD_human |
| Hgene | ENO1 | C0152013 | Adenocarcinoma of lung (disorder) | 1 | CTD_human |
| Hgene | ENO1 | C0520459 | Necrotizing Enterocolitis | 1 | CTD_human |
| Hgene | ENO1 | C0948089 | Acute Coronary Syndrome | 1 | CTD_human |
| Hgene | ENO1 | C1458155 | Mammary Neoplasms | 1 | CTD_human |
| Hgene | ENO1 | C2239176 | Liver carcinoma | 1 | CTD_human |
| Hgene | ENO1 | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |
| Tgene | COL4A2 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
| Tgene | COL4A2 | C0027726 | Nephrotic Syndrome | 1 | CTD_human |
| Tgene | COL4A2 | C0149925 | Small cell carcinoma of lung | 1 | CTD_human |
| Tgene | COL4A2 | C3280970 | PORENCEPHALY 2 | 1 | UNIPROT |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|